Nigeria takes an integrated approach

Home

News
Press Releases and Articles
Calendar of Events
How to Help
Gates Foundation Grant to GAELF

The Global Alliance
Global Alliance History
Goals
Global Alliance Structure
Executive Group
Partnerships
GAELF Logo
LF Webring

About LF
What is LF?
How is LF Contracted?
How is LF Diagnosed?
Prevent/Eliminate LF
Manage LF
LF and Children
Additional Treatment Benefits
LF Slideshow
In Depth Disease Info

Where is LF?
Countries and Map List
Moving Forward
Starting Out
Success Stories

Progress and Plans
Elimination Strategy
Operational Research
Progress to Date
Economics of LF
Return on Investment
The Way Ahead
Highlighted Programmes
Burkina Faso
Sri Lanka

For the Media
Press Release Archive
Press Kits
Photos
Articles
Video Clips
Media Contacts
FAQs
Publications
LF News
Annual Reports
General Publications
Training Material
Videos
Journal Articles & Other Pubs
EG Updates
Gates Foundation

Nigeria takes an integrated approach

Distributing drugs to eliminate LF can be integrated into existing national and local public health strategies quickly and cost-effectively, often with little need for extra resources. For instance, two states in Nigeria distribute drugs to treat LF at the same time as they are treating river blindness (onchocerciasis) and schistosomiasis. Administrative and drug delivery resources have been shared between the LF and river blindness programmes, helping reduce costs for both. The schistosomiasis programme has grown in parallel with the LF programme and treated approximately 190,000 people in 2003. The LF mass drug administration programme reached 3.1 million people in 2003.